Kura Oncology, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Kura Oncology, Inc.
RECRUITINGPhase 1NCT06026410
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in...
Sponsor: Kura Oncology, Inc.Enrolling: 30020 locations
Solid Tumors With HRAS AlterationsNon Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+4
RECRUITINGPhase 1NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
The safety, tolerability, and antileukemic response of ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia will...
Sponsor: Kura Oncology, Inc.Enrolling: 17120 locations
AMLAML With Mutated NPM1Hematologic Malignancy+9